Luke, J., Fakih, M., Schneider, C., Chiorean, E. G., Bendell, J., Kristeleit, R., & Brana, I. (2023). Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors.
Citación estilo ChicagoLuke, Jason, Marwan Fakih, Charles Schneider, E. Gabriela Chiorean, Johanna Bendell, Rebecca Kristeleit, y Irene Brana. Phase I/II Sequencing Study of Azacitidine, Epacadostat, and Pembrolizumab in Advanced Solid Tumors. 2023.
Cita MLALuke, Jason, et al. Phase I/II Sequencing Study of Azacitidine, Epacadostat, and Pembrolizumab in Advanced Solid Tumors. 2023.
Precaución: Estas citas no son 100% exactas.